• Home
  • Syllabus
  • Events & Notices
  • Gallery
  • E-Content & SLM

MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS

Faculty 
FACULTY OF PHARMACEUTICAL SCIENCES
Department 
Pharmaceutical Science
Duration 
2 years
Modeof Admission 
GPAT score
Intake 
12
Eligibility 
B. Pharm. with at least 50% marks in aggregate or any other examination recognized by M.D. University, Rohtak as equivalent thereto, and must possess a valid GPAT score. In case GPAT qualified students are not available, the seats will be open to the other candidates on merit basis, on the basis of aggregate score of B.Pharmacy.
Last Modified 
 

MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS

Syllabus 
View 
SYLLABUS AND SCHEME OF EXAMINATION M.PHARM. DRUG REGULATORY AFFAIRS (DRA)Click here to View
M.Pharma Drug Regulatory AffairsClick here to View

Events @ MDU

No data to display

News @ MDU

SYLLABUS AND SCHEME OF EXAMINATION M.PHARM. DRUG REGULATORY AFFAIRS (DRA)
10/12/2018
Details
M.Pharma Drug Regulatory Affairs
1/1/2011
Details

x
Resource Name: WHO CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:ARUN NANDA
Remarks:WHO contents of Certificate of Pharmaceutical Product
Uploaded On:4/9/2020
Resource Name: CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:ARUN NANDA
Remarks:Certificate of Pharmaceutical Product
Uploaded On:4/9/2020
Resource Name: National Pharmacovigilance Programme of India
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:ARUN NANDA
Remarks:National Pharmacovigilance Programme of India -- look into the first few slides, up to the role of MAMC
Uploaded On:4/2/2020
Resource Name: WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:HARISH DUREJA
Remarks:WHO GMP-2
Uploaded On:4/1/2020
Resource Name: WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:HARISH DUREJA
Remarks:WHO GMP
Uploaded On:4/1/2020
Resource Name: ACTD
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:HARISH DUREJA
Remarks:ASEAN guidelines for dossier submission
Uploaded On:4/1/2020
Resource Name: UAE
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:HARISH DUREJA
Remarks:UAE
Uploaded On:4/1/2020
Resource Name: biosimilars regulations
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:ARUN NANDA
Remarks:biosimilar regulations
Uploaded On:4/1/2020
Resource Name: Consumer Protection Act
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
UploadedBy:ARUN NANDA
Remarks:This presentation gives an overview of CPA for the pharmacists.
Uploaded On:3/26/2020
x
Resource Name: biosimilars regulations
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:biosimilar regulations
Resource Name: UAE
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:UAE
Resource Name: ACTD
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:ASEAN guidelines for dossier submission
Resource Name: WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO GMP
Resource Name: WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO GMP-2
Resource Name: National Pharmacovigilance Programme of India
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:National Pharmacovigilance Programme of India -- look into the first few slides, up to the role of MAMC
Resource Name: CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:Certificate of Pharmaceutical Product
Resource Name: WHO CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO contents of Certificate of Pharmaceutical Product
x
No data to display
x
No data to display
x
Resource Name: Consumer Protection Act
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:This presentation gives an overview of CPA for the pharmacists.
x
No data to display
x
Resource Name:WHO CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO contents of Certificate of Pharmaceutical Product
Resource Name:CoPP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:Certificate of Pharmaceutical Product
Resource Name:National Pharmacovigilance Programme of India
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:National Pharmacovigilance Programme of India -- look into the first few slides, up to the role of MAMC
Resource Name:WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO GMP-2
Resource Name:WHO GMP
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:WHO GMP
Resource Name:ACTD
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:ASEAN guidelines for dossier submission
Resource Name:UAE
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:UAE
Resource Name:biosimilars regulations
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:biosimilar regulations
Resource Name:Consumer Protection Act
Program:MASTER OF PHARMACY - PHARMACEUTICS DRUG REG. AFFAIRS (853)
Semester:2
Remarks:This presentation gives an overview of CPA for the pharmacists.